Global Sterile Tubing Welder Market Share, Size, Analysis, Growth, Forecast: By Mode: Automatic, Manual; By Application: Blood Processing, Biopharmaceuticals, Diagnostic Laboratories, Others; By End User: Hospitals, Clinics, Blood Banks, Research Centres, Others; By Distribution Channel; Regional Analysis; Supplier Landscape; 2024-2032

Global Sterile Tubing Welder Market Outlook

The global sterile tubing welder market was valued at USD 2.23 billion in 2023, driven by the rising demand for personalised medicines, increasing prevalence of blood disorders, and rapidly expanding healthcare infrastructure of various nations. The market size is anticipated to grow at a CAGR of 4.8% during the forecast period of 2024-2032 to achieve a value of USD 3.40 billion by 2032.

Key Trends in the Market

A sterile tubing welder is used to create the antiseptic link between two equal-length thermoplastic tubes. A functioning closed system is produced by welding tube modules that are firmly fitted into the tube clamp assembly. The welder apparatus is widely used in biotechnology, pharmaceuticals, blood banks, diagnostic laboratories, and other businesses to synthesise DNA cells and blood plasma for use in a range of medicinal therapies. Before sending the biological sample to the labs for additional testing, it is moved to a tube that is totally sealed.

• A key trend accelerating the sterile tubing welder market expansion is the increased need for personalised medications. In addition, the market is propelled by the rising demand for blood and blood products, the development of cell therapy and genetics, and the rising incidence of blood illnesses.

• The rapidly expanding healthcare infrastructure of different nations around the world, the surge in health issues, diseases, and cancers, along with the growing initiatives by governments in terms of time and money to improving their nations' healthcare systems are further escalating the market growth.

• With such a large number of transfusions occurring, blood products are in great demand and are widely used, requiring sterile tubing. Inadequate storage, inappropriate handling during blood processing, and contamination of blood are some problems that are increasing demand for automated sterile tubing welders and driving the market.

Global Sterile Tubing Welder Market Analysis

Based on mode, the market is segmented into automatic and manual. The market on the basis of application can be divided into blood processing, biopharmaceuticals, and diagnostic laboratories, among others. Based on end use, the market can be segmented into hospitals, research clinics, and blood centres, among others. The regional markets for sterile tubing welder can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global sterile tubing welder market, covering their competitive landscape and latest developments like mergers, acquisitions, investments, and expansion plans.

• Terumo BCT, Inc.

• Sartorius AG

• Cytiva

• GenesisBPS

• Vante and SEBRA

• Others

Market Share by Mode

Based on mode, the automatic segment is anticipated to represent a significant portion of global sales due to its portability and convenience of use. Due to the enhanced weld quality and user-friendliness of these types of welding equipment, the automatic segment is anticipated to hold its dominant position throughout the forecast period, thereby aiding the sterile tubing welder market development.

The automatic sterile tubing welder enables welding speed and duration adjustments without the need for a qualified specialist. As a result of the equipment's faster welding pace than that of a professional welder, less labour is required. Therefore, it is anticipated that demand for these devices would rise due to higher production volumes, increased speeds, and decreased labour costs.

Market Share by Region

North America dominated the global market in the historical period and is anticipated to grow in the forecast period as well. An increase in the prevalence of chronic diseases, technological advancements, and a high demand for sterile and sanitary conditions to prevent contamination are some of the major factors influencing the growth of the sterile tubing welder market in this region. The increased incidence of chronic conditions in the United States is one of the primary factors fuelling the market's development.

Over the course of the forecast period, the Asia Pacific region is anticipated to have rapid growth, owing to the expansion of the pharmaceutical and biopharmaceutical industries along with an increase in the number of significant multinational corporations investing in research and development in this region.

Additionally, a surge in the geriatric population and the presence of the middle-class population significantly enhances the need for cutting-edge and reasonably priced sterile tubing welding devices in order to draw important medical device companies to the area. The market for sterile tubing welder will also benefit greatly from the significant growth of China's pharmaceutical and biotechnology industries.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Competitive Landscape

Terumo BCT, Inc., with its headquarters in the United States, provides customers in more than 130 countries with cutting-edge blood component, therapeutic apheresis, and cellular technologies. The business provides goods and services in the areas of whole blood processing, pathogen reduction technologies, cell therapy systems, therapeutic apheresis, and apheresis collections.

Sartorius AG, headquartered in Germany and founded in 1870, is one of the world's top suppliers of process and laboratory equipment for the biotechnology and mechatronics industries. The main areas of activity in its biotechnology segment are filtration, cell cultivation and fermentation, fluid management, purification, and laboratory applications.

Cytiva, with its headquarters in the United States conducts biological research to create novel vaccines, biologic medications, and cell and gene therapies. Since its founding in 1968, the business has innovated with a focus on the needs of its customers in 11 locations around Asia, Europe, and America.

Other market players include GenesisBPS and Vante and SEBRA, among others.

Key Highlights of the Report

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.